Synnat Pharma

2-{[(2S)-Oxiran-2-yl]methyl}-1H-isoindole-1,3(2H)-dione

Chemistry, 17 End Use API, 77 Related Intermediates

Manufacturers/Suppliers

17 Suppliers

17 Suppliers

MARKET PLACE

1 Intermediates

1 Intermediates

Also known as: 161596-47-0, (s)-n-glycidylphthalimide, (s)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione, 2-[(2s)-oxiran-2ylmethyl]-1h-isoindole-1,3(2h)-dione, 2-[[(2s)-oxiran-2-yl]methyl]isoindole-1,3-dione, 1h-isoindole-1,3(2h)-dione, 2-[(2s)-oxiranylmethyl]-

Molecular Formula

C₁₁H₉NO₃

Molecular Weight

203.19 g/mol

InChI Key

DUILGEYLVHGSEE-ZETCQYMHSA-N

1 2D Structure

2-{[(2S)-Oxiran-2-yl]methyl}-1H-isoindole-1,3(2H)-dione

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-[[(2S)-oxiran-2-yl]methyl]isoindole-1,3-dione

2.1.2 InChI

InChI=1S/C11H9NO3/c13-10-8-3-1-2-4-9(8)11(14)12(10)5-7-6-15-7/h1-4,7H,5-6H2/t7-/m0/s1

2.1.3 InChI Key

DUILGEYLVHGSEE-ZETCQYMHSA-N

2.1.4 Canonical SMILES

C1C(O1)CN2C(=O)C3=CC=CC=C3C2=O

2.1.5 Isomeric SMILES

C1[C@@H](O1)CN2C(=O)C3=CC=CC=C3C2=O

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 161596-47-0

2. (s)-n-glycidylphthalimide

3. (s)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione

4. 2-[(2s)-oxiran-2ylmethyl]-1h-isoindole-1,3(2h)-dione

5. 2-[[(2s)-oxiran-2-yl]methyl]isoindole-1,3-dione

6. 1h-isoindole-1,3(2h)-dione, 2-[(2s)-oxiranylmethyl]-

7. 2-[(2s)-2-oxiranylmethyl]-1h-isoindole-1,3(2h)-dione

8. 2-[(2s)-oxiran-2-ylmethyl]-1h-isoindole-1,3(2h)-dione

9. 1h-isoindole-1,3(2h)-dione, 2-[(2s)-2-oxiranylmethyl]-

10. 1h-isoindole-1,3(2h)-dione, 2-((2s)-2-oxiranylmethyl)-

11. Mfcd04973350

12. Unii-9ga7c6l4s5

13. Glycidyl Phthalimide, (s)-

14. Schembl78821

15. N-[(s)-glycidyl]phthalimide

16. 9ga7c6l4s5

17. (s)-( )-glycidyl Phthalimide

18. Dtxsid80352110

19. Zinc119624

20. Cs-m1834

21. N-((s)-(+)-glycidyl)phthalimide

22. (s)-glycidyl Phthalimide [usp-rs]

23. Akos016842501

24. Am84540

25. Gs-3726

26. (s)-2-oxiranylmethylisoindole-1,3-dione

27. Ac-23326

28. N-[(2s)-oxiran-2-ylmethyl]-phthalimide

29. G0328

30. (s)-2-(oxiran-2-ylmethy)isoindoline-1,3-dione

31. 596g470

32. A853175

33. (s)-2-(oxiran-2-yl Methyl)isoindoline-1,3-dione

34. (s)-2-(oxiran-2-ylmethyl) Isoindoline-1,3-dione

35. 2-(((s)-oxiran-2-yl)methyl)isoindoline-1,3-dione

36. Q-102521

37. (s)-2-[2-oxiranylmethyl]-1h-isoindole-1,3(2h)-dione

38. 2-[(2s)-2-oxiranylmethyl]-1h-isoindole-1,3(2h)dione

39. (s)-2-(oxiran-2-ylmethyl)-1h-isoindole-1,3(2h)-dione

40. 2-[(25)-2-oxiranylmethyl]-1h-isoindole-1,3(2h)-dione

41. 2-[(2s)-2-oxiranylmethyl]-1h-isoindole-1,3-(2h)-dione

42. 2-[(2s)-oxiran-2yl Methyl]-1h-isoindole-1,3(2h)dione

43. (s)-(+)-n-(2,3-epoxypropyl)phthalimide, >=99.0% (gc)

44. 2-{[(2s)-oxiran-2-yl]methyl}-1h-isoindole-1,3(2h)-dione

45. 2-{[(2s)-oxiran-2-yl]methyl}-2,3-dihydro-1h-isoindole-1,3-dione

2.3 Create Date

2005-07-08

3 Chemical and Physical Properties

Molecular Formula	C₁₁H₉NO₃
Molecular Weight	203.19 g/mol
XLogP3	1.2
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	2
Exact Mass	203.058243149 g/mol
Monoisotopic Mass	203.058243149 g/mol
Topological Polar Surface Area	49.9 Å²
Heavy Atom Count	15
Formal Charge	0
Complexity	291
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

Reset Filter

Ask Us

Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

Contact Supplier

India

Virtual Booth

Digital Content

5-Chlorothiophene-2-cabonyl chloride

PDF Supplier PDF

URL Supplier Web Content

CAS Number

42518-98-9

End Use API

Rivaroxaban

About the Company

Synnat Pharma is a fast-growing pharmaceutical company dedicated to the identification, development, prod...

Synnat Pharma is a fast-growing pharmaceutical company dedicated to the identification, development, production and distribution of potent phytochemicals and botanical extracts. APIs manufactured by Synnat are used by major drug formulators worldwide. Manufacturing activities are carried out as per ICH cGMP guidelines and several conventional and modern techniques are used for the isolation, semi-synthesis and purification of its products. Synnat Pharma has a presence in semi-regulated and non-regulated markets and is now entering regulated markets.